BNP PARIBAS ASSET MANAGEMENT Holding S.A. Buys 6,826 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

BNP PARIBAS ASSET MANAGEMENT Holding S.A. boosted its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 5.9% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 122,721 shares of the company's stock after acquiring an additional 6,826 shares during the period. BNP PARIBAS ASSET MANAGEMENT Holding S.A. owned 0.10% of Henry Schein worth $8,946,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of HSIC. Swedbank AB purchased a new position in Henry Schein in the first quarter worth about $215,998,000. ING Groep NV purchased a new position in Henry Schein in the third quarter worth about $63,226,000. Thompson Siegel & Walmsley LLC purchased a new position in Henry Schein in the second quarter worth about $46,683,000. SG Americas Securities LLC raised its holdings in shares of Henry Schein by 1,622.3% during the third quarter. SG Americas Securities LLC now owns 458,828 shares of the company's stock valued at $33,449,000 after purchasing an additional 432,187 shares during the last quarter. Finally, Nuance Investments LLC raised its holdings in shares of Henry Schein by 22.3% during the third quarter. Nuance Investments LLC now owns 2,278,081 shares of the company's stock valued at $166,072,000 after purchasing an additional 414,748 shares during the last quarter. 96.62% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Henry Schein

In related news, SVP Lorelei Mcglynn sold 21,035 shares of the company's stock in a transaction on Friday, September 6th. The shares were sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the sale, the senior vice president now owns 71,833 shares of the company's stock, valued at $4,978,026.90. This represents a 22.65 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, COO Michael S. Ettinger sold 12,240 shares of the stock in a transaction on Monday, November 18th. The shares were sold at an average price of $75.00, for a total transaction of $918,000.00. Following the completion of the sale, the chief operating officer now directly owns 87,706 shares in the company, valued at approximately $6,577,950. This represents a 12.25 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.14% of the company's stock.

Analysts Set New Price Targets

Several research firms have recently weighed in on HSIC. Barrington Research reissued an "outperform" rating and set a $82.00 price objective on shares of Henry Schein in a report on Wednesday, November 6th. Robert W. Baird decreased their price objective on shares of Henry Schein from $92.00 to $82.00 and set an "outperform" rating for the company in a report on Wednesday, August 7th. UBS Group decreased their price objective on shares of Henry Schein from $75.00 to $72.00 and set a "neutral" rating for the company in a report on Wednesday, August 7th. Evercore ISI boosted their price objective on shares of Henry Schein from $70.00 to $74.00 and gave the company an "in-line" rating in a report on Tuesday, October 8th. Finally, StockNews.com raised shares of Henry Schein from a "sell" rating to a "hold" rating in a report on Thursday, November 7th. Six analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $78.89.

Henry Schein Price Performance

Shares of HSIC traded up $1.76 during mid-day trading on Monday, reaching $76.84. The stock had a trading volume of 2,611,430 shares, compared to its average volume of 1,399,551. The firm has a market cap of $9.58 billion, a price-to-earnings ratio of 31.62, a PEG ratio of 2.15 and a beta of 0.87. Henry Schein, Inc. has a 12 month low of $63.67 and a 12 month high of $82.63. The business has a fifty day moving average of $70.89 and a 200 day moving average of $69.73. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, topping analysts' consensus estimates of $1.17 by $0.05. The business had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The company's revenue was up .4% on a year-over-year basis. During the same period in the prior year, the business posted $1.32 earnings per share. Equities analysts predict that Henry Schein, Inc. will post 4.78 EPS for the current year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.